Banco Bilbao Vizcaya Argentaria S.A. increased its stake in Mettler-Toledo International, Inc. (NYSE: MTD) by 7.6% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,715 shares of the medical instruments supplier's stock after acquiring an additional 616 shares
Mettler-Toledo (MTD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Although the revenue and EPS for Mettler-Toledo (MTD) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
MTD beats Q4 estimates as adjusted EPS jumps 8% Y/Y and sales rise to $1.13B, led by solid growth across Laboratory, Industrial and Food Retail.
Mettler-Toledo (MTD) came out with quarterly earnings of $13.36 per share, beating the Zacks Consensus Estimate of $12.76 per share. This compares to earnings of $12.41 per share a year ago.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Mettler-Toledo International Inc. (MTD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Mettler-Toledo International Inc. (MTD) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Mettler-Toledo International Inc. (MTD) Presents at Evercore 8th Annual Healthcare Conference Transcript
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MTD posted stronger-than-expected Q3 results, lifted by segment growth and solid guidance for 2025 and 2026.